<SEC-DOCUMENT>0001140361-23-035270.txt : 20230720
<SEC-HEADER>0001140361-23-035270.hdr.sgml : 20230720
<ACCEPTANCE-DATETIME>20230719200919
ACCESSION NUMBER:		0001140361-23-035270
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230720
DATE AS OF CHANGE:		20230719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			D-Wave Quantum Inc.
		CENTRAL INDEX KEY:			0001907982
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-267124
		FILM NUMBER:		231097893

	BUSINESS ADDRESS:	
		STREET 1:		3033 BETA AVENUE
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5G4M9
		BUSINESS PHONE:		(604) 630-1428

	MAIL ADDRESS:	
		STREET 1:		3033 BETA AVENUE
		CITY:			BURNABY
		STATE:			A1
		ZIP:			V5G4M9
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>brhc20056126_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;">Filed Pursuant to Rule 424(b)(3)</div>
      <div style="text-align: right; font-weight: bold;">Registration No. 333-267124</div>
      <div style="text-align: right; font-weight: bold;"> <br>
      </div>
      <div style="font-weight: bold;">PROSPECTUS SUPPLEMENT NO. 24</div>
      <div style="font-weight: bold;">(to Prospectus dated October 26, 2022)</div>
      <div> <br>
      </div>
      <div style="text-align: center;"><img src="image00001.jpg">
        <div><br>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">D-WAVE QUANTUM INC.</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">COMMON SHARES</div>
      <div style="text-align: center; font-weight: bold;">WARRANTS TO PURCHASE COMMON SHARES</div>
      <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING EXCHANGEABLE SHARES</div>
      <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING D-WAVE OPTIONS</div>
      <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING D-WAVE WARRANTS</div>
      <div style="text-align: center; font-weight: bold;">COMMON SHARES UNDERLYING WARRANTS</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div> <br>
      </div>
      <div>This prospectus supplement updates, amends and supplements the prospectus contained in our Registration Statement on Form S-1, effective as of October 26, 2022 (as supplemented or amended from time to time, the &#8220;Prospectus&#8221;) (Registration No.
        333-267124).</div>
      <div> <br>
      </div>
      <div>This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
        on July 19, 2023 (the &#8220;Form 8-K&#8221;). Accordingly, we have attached the Form 8-K to this prospectus supplement.</div>
      <div> <br>
      </div>
      <div>This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto,
        except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.</div>
      <div> <br>
      </div>
      <div>Our shares of common stock, par value $0.0001 (&#8220;Common Shares&#8221;), and warrants to purchase Common Shares (&#8220;Warrants&#8221;), each whole Warrant exercisable for 1.4541326 Common Shares at an exercise price of $11.50, are listed on the New York Stock
        Exchange (the &#8220;NYSE&#8221;) under the symbols &#8220;QBTS&#8221; and &#8220;QBTS.WT,&#8221; respectively. On July 18, 2023, the last reported sales prices for the Common Shares and Warrants on the NYSE were $2.89 and $0.24, respectively.</div>
      <div> <br>
      </div>
      <div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div style="font-weight: bold;">Investing in our securities involves a high degree of risk. See &#8220;<u>Risk Factors</u>&#8221; beginning on page 50 of the Prospectus for a discussion of applicable information that should be considered in connection with an
        investment in our securities.</div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div style="font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete.
        Any representation to the contrary is a criminal offense.</div>
      <div style="font-weight: bold;"> <br>
      </div>
      <div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">The date of this prospectus supplement is July 19, 2023.</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div>
          <hr align="center" style="border-width: 4px medium 1px; border-style: solid none; border-color: black currentColor; border-image: none; height: 10px; text-align: center; color: rgb(255, 255, 255); margin-right: auto; margin-left: auto; background-color: rgb(255, 255, 255);">
          <div style="text-align: right; font-weight: bold;">
            <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
            <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
            <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
            <div style="text-align: center; font-weight: bold;"><br>
            </div>
            <div style="text-align: center; font-weight: bold;">
              <hr noshade="noshade" align="center" style="border: currentColor; border-image: none; width: 30%; height: 2px; color: rgb(0, 0, 0); margin-right: auto; margin-left: auto; background-color: rgb(0, 0, 0);"></div>
            <div style="text-align: center;"><br>
            </div>
            <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 8-K</div>
            <div style="text-align: center; font-weight: bold;"><font style="color: rgb(0, 0, 0);"><br>
              </font></div>
            <div style="text-align: center; font-weight: bold;">
              <hr noshade="noshade" align="center" style="border: currentColor; border-image: none; width: 30%; height: 2px; color: rgb(0, 0, 0); margin-right: auto; margin-left: auto; background-color: rgb(0, 0, 0);"></div>
            <div style="text-align: center;"><br>
            </div>
            <div style="text-align: center; font-weight: bold;">CURRENT REPORT</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</div>
            <div style="text-align: center; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">Date of Report (Date of earliest event reported): July 13, 2023</div>
            <div style="text-align: center; font-weight: bold;"><br>
            </div>
            <div style="text-align: center; font-weight: bold;">
              <hr noshade="noshade" align="center" style="border: currentColor; border-image: none; width: 30%; height: 2px; color: rgb(0, 0, 0); margin-right: auto; margin-left: auto; background-color: rgb(0, 0, 0);"></div>
            <div style="text-align: center;"><br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">D-Wave Quantum Inc.<br>
            </div>
            <div style="text-align: center; font-weight: bold;">(Exact Name of Registrant as Specified in Its Charter)</div>
            <div style="text-align: center; font-weight: bold;"><br>
            </div>
            <div style="text-align: center; font-weight: bold;">
              <hr noshade="noshade" align="center" style="border: currentColor; border-image: none; width: 30%; height: 2px; color: rgb(0, 0, 0); margin-right: auto; margin-left: auto; background-color: rgb(0, 0, 0);"></div>
            <div style="text-align: center;"><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="z0a58fd22f95b4297a2d00cbb7ea50c2a">

                <tr>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware<br>
                    </div>
                  </td>
                  <td style="width: 33.92%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">001-41468<br>
                    </div>
                  </td>
                  <td style="width: 33%; vertical-align: top;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">84-1068854<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 33%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or other jurisdiction of incorporation or organization)</div>
                  </td>
                  <td style="width: 33.92%; text-align: center; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">(Commission File Number)</div>
                  </td>
                  <td style="width: 33%; text-align: center; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer Identification No.)</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">3033 Beta Avenue<br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Burnaby, British Columbia</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Canada</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">V5G 4M9<br>
            </div>
            <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">(604) 630-1428</div>
            <div style="text-align: center; font-weight: bold;">(Registrant&#8217;s telephone number, including area code)</div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;">N/A</div>
            <div style="text-align: center; font-weight: bold;">(Former name or former address, if changed since last report)</div>
            <div style="text-align: center; font-weight: bold;"><br>
            </div>
            <div style="text-align: center; font-weight: bold;">
              <hr noshade="noshade" align="center" style="border: currentColor; border-image: none; width: 30%; height: 2px; color: rgb(0, 0, 0); margin-right: auto; margin-left: auto; background-color: rgb(0, 0, 0);">
              <div><br>
              </div>
            </div>
            <div style="text-align: left; font-weight: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
              under any of the following provisions:</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="zd2a7f5d1eaf9465c8e9c05ce9d09aec3" class="DSPFListTable">

                <tr>
                  <td style="width: 15.35pt; text-align: center; color: rgb(51, 51, 51); vertical-align: top;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="zbc5249b60e1143e48dfc1a4e5f63b810" class="DSPFListTable">

                <tr>
                  <td style="width: 15.35pt; text-align: center; color: rgb(51, 51, 51); vertical-align: top;">&#9744;</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="z5b3d49498dbe4d4e859137631d6a76cc" class="DSPFListTable">

                <tr>
                  <td style="width: 15.35pt; text-align: center; color: rgb(51, 51, 51); vertical-align: top;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="zd447f86a915c48a9b8c11e1541381842" class="DSPFListTable">

                <tr>
                  <td style="width: 15.35pt; text-align: center; color: rgb(51, 51, 51); vertical-align: top;">&#9744;<br>
                  </td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: left; font-weight: normal;">Securities registered pursuant to Section 12(b) of the Act:</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="z552bf75b97eb40c9a9e168f2fa1d0488">

                <tr>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of each class</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Trading Symbol(s)</div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name of each exchange on which registered</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">Common stock, par value $0.0001 per share<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">QBTS<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">New York Stock Exchange<br>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">Warrants, each whole warrant exercisable for 1.4541326 shares of common stock at an exercise price of $11.50<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">QBTS.WT<br>
                    </div>
                  </td>
                  <td style="width: 2%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 32%; vertical-align: bottom;">
                    <div style="text-align: center; color: rgb(0, 0, 0);">New York Stock Exchange<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: left; font-weight: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
              (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="z18fb4833a72446de993dd02a7e372979">

                <tr>
                  <td style="width: 95.31%; vertical-align: bottom;">
                    <div style="text-align: right; color: rgb(0, 0, 0);">Emerging growth company</div>
                  </td>
                  <td style="width: 1.17%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 3.51%; vertical-align: bottom;">
                    <div style="color: rgb(51, 51, 51);">&#9746;<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="z80e942349c4d4212969dba221bd88830">

                <tr>
                  <td style="width: 95.31%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
                      standards provided pursuant to Section 13(a) of the Exchange Act.</div>
                  </td>
                  <td style="width: 1.17%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 3.51%; vertical-align: bottom;">
                    <div style="color: rgb(51, 51, 51);">&#9744;<br>
                    </div>
                  </td>
                </tr>

            </table>
            <div><br>

              <hr align="center" style="border-width: 1px medium 4px; border-style: solid none; border-color: black currentColor; border-image: none; height: 10px; text-align: center; color: rgb(255, 255, 255); margin-right: auto; margin-left: auto; background-color: rgb(255, 255, 255);"></div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
            </div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="z1d01e2fdcf6f40f58e9f35ae1bf351eb" class="DSPFListTable">

                <tr>
                  <td style="width: 72pt; font-weight: bold; vertical-align: top;">Item 1.01</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold;">Entry into a Material Definitive Agreement.</div>
                  </td>
                </tr>

            </table>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">On July 13, 2023, D-Wave Quantum Inc. (the "Company") entered into the Limited Waiver and Second Amendment to Loan and Security
              Agreement (the &#8220;Amendment&#8221;) with PSPIB Unitas Investments II Inc., an affiliate of PSP Investments, (&#8220;PSPIB&#8221;) waiving and amending certain conditions to the Loan and Security Agreement dated as of April 13, 2023, by and among the Company and
              its subsidiaries and PSPIB (as amended pursuant to that certain First Amendment to Loan and Security Agreement dated as of June 16, 2023) (the &#8220;Term Loan&#8221;).</div>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">Under the Amendment, PSPIB agreed to waive certain conditions and provide the Company funding under Loan B (as defined in the Term
              Loan). Under the Term Loan, prior to the issuance of Loan B, the Company was to deliver PSPIB a board-approved operating budget and plan for the Company&#8217;s fiscal years 2023 to 2027 satisfactory to PSPIB (the &#8220;Operating Budget&#8221;). Under the
              Amendment, PSPIB waived this condition to funding Loan B and extended the deadline for the Company to deliver the Operating Budget to August 31, 2023.</div>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">PSPIB also agreed to waive the condition that, prior to the issuance of Loan B, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;)
              shall have nominated one additional director that is either an employee of PSPIB or an independent director selected by the Board from a list of at least three nominees provided by PSPIB (the &#8220;Nomination Requirement&#8221;). Under the Amendment,
              the Company must now fulfil the Nomination Requirement at PSPIB&#8217;s option upon five business days&#8217; notice to the Company.</div>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">Under the Term Loan, the Company was required to notify PSPIB of any patent, trademark or copyright registration or filing within
              five business days following registration or filing. The Amendment modifies the notification deadline, requiring the Company to notify PSPIB of such registrations or filings within five business days after the end of each month.</div>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">Although the Company was able to draw on Loan B, there can be no assurance that it will be able to meet the conditions necessary
              to draw on Loan C (as defined in the Term Loan).</div>
            <div style="font-weight: normal;"><br>
            </div>
            <div style="text-align: justify; font-weight: normal;">The above description of the material terms of the Amendment is qualified in its entirety by the Amendment attached as Exhibit
              10.1 to this Current Report on Form 8-K, which is incorporated by reference into this Current Report on Form 8-K.</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="z9f035949d30945c38479c7a5cc46d516" class="DSPFListTable">

                <tr>
                  <td style="width: 72pt; font-weight: bold; vertical-align: top;">Item 2.03</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold;">Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="text-align: left; text-indent: -72pt; margin-left: 72pt; font-weight: normal;">The information set forth above under Item 1.01 is hereby incorporated by reference into this
              Item 2.03.</div>
            <div><br>
            </div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;" id="zea45c1395220499788ba6eba5dbfc560" class="DSPFListTable">

                <tr>
                  <td style="width: 72pt; font-weight: bold; vertical-align: top;">Item 9.01.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="text-align: left; font-weight: normal;">(d)&#160; Exhibits</div>
            <div style="text-align: left;"><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="z0a1462e125b74b02a91eba227bffb2e7">

                <tr>
                  <td style="width: 25%; vertical-align: top;">
                    <div style="font-weight: bold;"><u>Exhibit Number</u></div>
                  </td>
                  <td style="width: 75%; vertical-align: top;">
                    <div style="font-weight: bold;"><u>Description</u></div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 25%; vertical-align: top;">&#160;</td>
                  <td style="width: 75%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 25%; vertical-align: top;">
                    <div>10.1</div>
                  </td>
                  <td style="width: 75%; vertical-align: top;">
                    <div>Limited Waiver and Second Amendment to Loan and Security Agreement, dated as of July 13, 2023, by and among PSPIB Unitas Investments II Inc. and D-Wave Quantum Inc.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 25%; vertical-align: top;">&#160;</td>
                  <td style="width: 75%; vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 25%; vertical-align: top;">
                    <div>104</div>
                  </td>
                  <td style="width: 75%; vertical-align: top;">
                    <div>Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
            </div>
            <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
            <div>&#160;</div>
            <div style="text-align: left; font-weight: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
              behalf by the undersigned hereunto duly authorized.</div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;" id="ze576f877c960456fad6854a049f6896f">

                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td colspan="2" style="vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0); font-weight: bold;">D-Wave Quantum Inc.</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 44.51%; vertical-align: bottom;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Dated: July 19, 2023</div>
                  </td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">By:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 2px; border-bottom-style: solid;">
                    <div>/s/ Alan Baratz</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Name:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Alan Baratz</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 50%; vertical-align: bottom;">&#160;</td>
                  <td style="width: 5%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">Title:</div>
                  </td>
                  <td style="width: 44.51%; vertical-align: bottom;">
                    <div style="color: rgb(0, 0, 0);">President &amp; Chief Executive Officer</div>
                  </td>
                </tr>

            </table>
          </div>
          <div style="text-align: right; font-weight: bold;"> <br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: right; font-weight: bold;">Exhibit 10.1</div>
        </div>
        <div>
          <div>
            <div>
              <div><br>
              </div>
              <div style="text-align: center; font-weight: bold;">LIMITED WAIVER AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT</div>
              <div><br>
              </div>
              <div style="text-align: justify; text-indent: 36pt;">LIMITED WAIVER AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this &#8220;<u>Amendment</u>&#8221;),

                dated as of July 13, 2023, by and between D-WAVE QUANTUM INC., a Delaware corporation (the &#8220;<u>Borrower</u>&#8221;), and the Lender (as defined below) party hereto.</div>
              <div>&#160;</div>
              <div style="text-align: center;"><font style="font-weight: bold;"><u>W</u>&#160;<u>I</u>&#160;<u>T</u>&#160;<u>N</u>&#160;<u>E</u>&#160;<u>S</u>&#160;<u>S</u>&#160;<u>E</u>&#160;<u>T</u>&#160;<u>H</u></font><u>:</u></div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">WHEREAS, the Borrower, D-Wave Systems Inc., a British Columbia corporation, D-Wave US Inc., a Delaware corporation, D-Wave Government Inc.,
                a Delaware corporation, D-Wave Commercial Inc., a Delaware corporation, D-Wave International Inc., a Canadian corporation, D-Wave Quantum Solutions Inc., a Canadian corporation, Omni Circuit Boards Ltd., a British Columbia corporation, DPCM
                Capital, Inc., a Delaware corporation, 1372929 B.C. Ltd, a British Columbia corporation, 1372934 B.C. LTD., a British Columbia corporation, DWSI Canada Holdings ULC, a British Columbia corporation, D&#8209;Wave Quantum Technologies Inc., a
                British Columbia corporation, and each other Person hereafter joined thereto as a guarantor (collectively or individually, as the context may dictate, the &#8220;<u>Guarantors</u>&#8221; and together
                with the Borrower, the &#8220;<u>Loan Parties</u>&#8221;) and PSPIB Unitas Investments II Inc., a Canadian corporation, as Collateral and as Lender (the &#8220;<u>Lender</u>&#8221;),
                are parties to that certain Loan and Security Agreement, dated as of April 13, 2023 (as amended pursuant to that certain First Amendment to Loan and Security Agreement dated as of June 16, 2023, and as further amended, modified,
                supplemented, renewed, restated or replaced from time to time, the &#8220;<u>Existing Loan Agreement</u>&#8221;);</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, the
                  Borrower has failed to meet certain of the conditions precedent associated with the funding of Loan B under the Existing Loan Agreement;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">WHEREAS</font>, the
                  Borrower has requested certain amendments to the Existing Loan Agreement such that, notwithstanding the failure to meet such conditions precedent, the Lender will fund Loan B under the Existing Loan Agreement, and the Lender party hereto
                  has agreed to such amendments, subject to the terms and conditions hereof; and</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;"><font style="font-weight: bold;">NOW, THEREFORE</font>, in
                  consideration of the covenants and agreements contained herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Defined Terms</u>.&#160; Capitalized terms used but not defined herein shall have the respective meanings assigned to such terms in the Existing Loan Agreement, as amended by this Amendment (the &#8220;<u>Amended Loan Agreement</u>&#8221;).</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limited Waiver</u>.&#160; Subject to the terms and conditions set forth herein, the Lender hereby waives certain of the conditions precedent to its obligation to make Loan B set forth in Section 3.2(h) of the
                    Amended Loan Agreement.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">The limited waiver set forth in this Section 2 (the &#8220;<u>Conditions Precedent Waiver</u>&#8221;)
                is limited to the extent expressly set forth above and no other condition precedent to the obligation to make Loan B, terms, covenants or provisions of the Amended Loan Agreement or any other Loan Document shall in any way be affected
                hereby.&#160; The Conditions Precedent Waiver is granted only with respect to those conditions precedent set forth in Section 3.2(h) of the Amended Loan Agreement agreed between the Borrower and the Lender, and shall not apply to any other
                condition precedent to the obligation of the Lender to make Loan B, or any terms of the Amended Loan Agreement, or any actual or prospective default or breach of any other provision of the Amended Loan Agreement or any other Loan Document.&#160;
                The Conditions Precedent Waiver shall not in any manner create a course of dealing or otherwise impair the future ability of the Lender to declare a Default or Event of Default under or otherwise enforce the conditions precedent for the
                obligation to make Loan C or any other terms of the Amended Loan Agreement or any other Loan Document with respect to any matter other than the Conditions Precedent Waiver.</div>
              <div>&#160;</div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <!--PROfilePageNumberReset%Num%2%- % -%-->
              <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendments to Existing Loan Agreement</u>.&#160; Subject to, and in accordance with, the terms and conditions set forth herein, including the satisfaction (or waiver by the Lender) of all conditions precedent
                    set forth in <u>Section 4</u> below, the Existing Loan Agreement is hereby amended as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Section 3.2(h)(iii) of the
                    Existing Loan Agreement is hereby amended and restated as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 40.5pt; margin-left: 36pt;">&#8220;[reserved];&#8221;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Section 3.2(h)(vi) of the
                    Existing Loan Agreement is hereby amended and restated as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">&#8220;[reserved];&#8221;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Section 4.8(b) of the
                    Existing Loan Agreement is hereby amended and restated as follows:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt; margin-left: 40.5pt;">&#8220;(b)&#160;&#160;&#160;&#160;&#160; Borrower
                    shall, within five (5) Business Days after the end of each month, notify Lenders of any federal registration or filing by Borrower of any patent or patent application, or trademark or trademark application, or copyright or copyright
                    application and shall promptly execute and deliver to Lenders any grants of security interests in same, in form acceptable to Lenders, to file with the United States Patent and Trademark Office or the United States Copyright Office or
                    the Canadian Intellectual Property Office, as applicable.&#8221;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Section 6.10 of the Existing
                    Loan Agreement is hereby amended by inserting the following clauses (e) and (f) at the end thereof:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 31.5pt; margin-left: 40.5pt;">&#8220;(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The
                    Borrower shall have delivered a board-approved operating budget and plan for Borrower&#8217;s fiscal years 2023 through 2027 that is satisfactory to the Lender on or prior to August 31, 2023.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 31.5pt; margin-left: 40.5pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the
                    Lenders&#8217; option, upon five (5) Business Days&#8217; notice to the Borrower, the Board of Directors shall have nominated one additional director that is either (i) an employee of the Lender or (ii) an independent director selected by the Board
                    of Directors from a list of at least three potential directors provided by the Lender.&#8221;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Condition to Effectiveness</u>.&#160; The effectiveness of this Amendment is subject to the Lender having received executed counterparts hereof from the Borrower and the Lender (the date of such satisfaction
                    (or waiver) being the &#8220;Amendment Effective Date&#8221;).</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representations and Warranties</u>.&#160; Each Loan Party hereby represents and warrants, on and as of the Amendment Effective Date and after giving effect to this Amendment, that:</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160; &#160; &#160; the representations and
                    warranties set forth in Section 5 of the Existing Loan Agreement and in each other Loan Document are true and correct in all material respects on and as of the Amendment Effective Date with the same effect as though made on and as of
                    such date, except to the extent such representations and warranties expressly relate to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date; provided that any representation and
                    warranty that is qualified as to &#8220;materiality,&#8221; &#8220;Material Adverse Effect&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates;</div>
              <div>&#160;</div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">- 2 -</font></div>
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;no event has occurred or
                    exists that would constitute a Default or an Event of Default;</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Amendment has been duly
                    executed and delivered by the Borrower and this Amendment and the Amended Loan Agreement constitute the legal, valid and binding obligations of Borrower, enforceable against it in accordance with their respective terms, except as the
                    enforceability thereof may be limited by bankruptcy, insolvency or other similar laws of general application relating to or affecting the enforcement of creditors&#8217; rights or by general principles of equity.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the execution, delivery and
                    performance of this Amendment and the performance by each Loan Party has been duly authorized by all necessary action on the part of Borrower and each Subsidiary. No authorization, consent, approval, license or exemption of, and no
                    registration, qualification, designation, declaration or filing with, or notice to, any Person is, was or will be necessary to (a) the valid execution and delivery of this Amendment, or (b) the performance of Borrower&#8217;s or any
                    Subsidiary&#8217;s obligations under this Amendment or the Amended Loan Agreement.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">6.&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Effects on Loan Documents</u>.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On and after the
                    effectiveness of this Amendment, each reference in any Loan Document to &#8220;the Loan Agreement&#8221; shall mean and be a reference to the Amended Loan Agreement and each reference in the Existing Loan Agreement to &#8220;this Agreement,&#8221; &#8220;hereunder,&#8221;
                    &#8220;hereof&#8221; or words of like import shall mean and be a reference to the Amended Loan Agreement.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as specifically
                    amended herein, all Loan Documents (including the guaranty and all Liens granted thereunder in respect of the Obligations) shall continue to be in full force and effect and are hereby in all respects ratified and confirmed.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The execution, delivery and
                    effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Lender or the Collateral Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents (except as
                    expressly provided herein) or in any way limit, impair or otherwise affect the rights and remedies of the Collateral Agent or the Lenders under the Loan Documents. This Amendment and the Amended Loan Agreement shall not constitute a
                    novation of the Existing Loan Agreement or the other Loan Documents.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 72pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Loan Parties and the
                    other parties hereto hereby acknowledge and agree that, on and after the Amendment Effective Date, this Amendment shall constitute a Loan Document for all purposes of the Amended Loan Agreement.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER.</u> THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, AND THE TERMS OF SECTION 5-1401 OF
                    THE NEW YORK GENERAL OBLIGATIONS LAW SHALL APPLY. PURSUANT TO SECTION 5-1402 OF THE NEW YORK GENERAL OBLIGATION LAWS, EACH OF BORROWER AND LENDER HEREBY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED
                    IN THE STATE OF NEW YORK. BORROWER AND LENDER HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AMENDMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREIN, INCLUDING
                    CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW OR STATUTORY CLAIMS.</div>
              <div>&#160;</div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">- 3 -</font></div>
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div style="text-align: justify; text-indent: 36pt;">8.&#160;&#160;&#160; &#160; &#160;&#160; <u>Headings</u>. Section headings used herein are for convenience of reference only, are not part of this Amendment and are not to affect the construction of, or to be taken into consideration in
                    interpreting, this Amendment.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>.&#160; The provisions of this Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted by the Amended Loan
                    Agreement.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>. In the event any one or more of the provisions contained in this Amendment should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of
                    the remaining provisions contained herein shall not in any way be affected or impaired thereby. The parties shall endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the
                    economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>.&#160; This Amendment may be executed in counterparts, each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Any signature
                    delivered by a party by facsimile or other electronic means of transmission (including email transmission of a PDF copy) shall be deemed to be an original signature hereto.</div>
              <div>&#160;</div>
              <div style="text-align: justify; text-indent: 36pt;">12.&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire Agreement</u>.&#160; This Amendment and the Loan Agreement as amended hereby and the other Loan Documents constitute the entire agreement, and supersede any prior agreements and contemporaneous oral
                    agreements, of the parties concerning their subject matter.</div>
              <div>&#160;</div>
              <div style="text-align: center; margin-left: 36pt;">[<font style="font-style: italic;">Signature Pages Follow</font>]</div>
              <div>&#160;</div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;">- 4 -</font></div>
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed under seal by their duly authorized officers, all as of the
                day and year first written above.</div>
              <div>&#160;</div>
              <table cellspacing="0" cellpadding="0" border="0" id="z205642a1c5c744a2a909d83147661812" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div style="font-weight: bold;">BORROWER:</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div style="font-weight: bold;">D-WAVE QUANTUM INC.</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                    <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                      <div>By:</div>
                    </td>
                    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="margin-left: 9pt;">/s/ Alan Baratz</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Name: Alan Baratz</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Title: Chief Executive Officer</div>
                    </td>
                  </tr>

              </table>
              <div><br>
              </div>
              <div style="text-align: center;">[Signature Page to Limited Waiver and Second Amendment]</div>
              <div><br>
              </div>
              <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
                <div class="BRPFPageBreak" style="page-break-after: always;">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
              </div>
              <table cellspacing="0" cellpadding="0" border="0" id="z9e090fddb3654de9a1dd7f63e0f4e77c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div style="font-weight: bold;">LENDER:</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>PSPIB UNITAS INVESTMENTS II INC.</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>as a Lender</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                    <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                      <div>By:<br>
                        </div>
                    </td>
                    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid black;">
                      <div style="margin-left: 9pt">
                        <div>/s/ Michael Larkin</div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Name: Michael Larkin</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Title: Authorized Signatory</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                    <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                      <div>By:<br>
                        </div>
                    </td>
                    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid black;">
                      <div style="margin-left: 9pt">
                        <div>/s/ Jonathan Ostrzega</div>
                      </div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Name: Jonathan Ostrzega</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 50%; vertical-align: top;">&#160;</td>
                    <td style="vertical-align: top;" colspan="2">
                      <div>Title: Authorized Signatory</div>
                    </td>
                  </tr>

              </table>
              <div><br>
              </div>
              <div style="text-align: center;">[Signature Page to Limited Waiver and Second Amendment]</div>
              <div><br>
              </div>
              <div><br>
              </div>
            </div>
            <div>
              <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
          </div>

        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  U 5H# 2(  A$! Q$!_\0
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MF1CZ #)KQG_AH[PY_P! O4__ !S_ !KJ_CWK']C?"O6F1MDUT@LX_?S#@_\
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MM%0ZC:O]IMO=AU7\03^.*^,[6XO]"U9)[=Y;+4+63@CY'C84 ?HE4;N$4LY
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M]O''_/\ 6W_?D4 ?9F!Z4M?&7_"]O''_ #_6W_?D4?\ "]O''_/];?\ ?D4
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AVG_!+PAI%]9ZG:1WWVBUE6XCWSY&Y#O';U%>K444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
